Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-043110
Filing Date
2014-07-15
Accepted
2014-07-15 16:07:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT NO. 6 v383919_424b3.htm 424B3 25812
2 GRAPHIC logo.jpg GRAPHIC 8165
  Complete submission text file 0001144204-14-043110.txt   38245
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-190897 | Film No.: 14975992
SIC: 2834 Pharmaceutical Preparations